5 COVID-19 The COVID-19 pandemic has significantly affected Zimmer Biomet’s financial results, but has not impacted the quality, safety and efficacy of our products. Prior to COVID-19, Zimmer Biomet developed comprehensive crisis response plans and initiated contingency drills – including for pandemic events – across our operations. This exercise helped prepare our business and create enhanced disaster recovery plans that have been a significant benefit throughout our response to COVID-19. Throughout 2021, we continued to aggressively secure our global supply chain and manage the unique challenges presented by each new COVID-19 wave. Due to these efforts, we continued to serve our customers without compromising product quality and safety. All of our manufacturing sites and distribution centers continued to operate throughout 2021 with enhanced safety protocols. Our vigilance and commitment to health and safety ensured our team members in each region had what they needed to operate in a safe environment and meet our operational commitments. Our enhanced safety protocols were openly shared with suppliers to further secure our supply chain. Most Zimmer Biomet team members who were not directly responsible for or involved in manufacturing operations and the supply chain worked from home as an added safety measure to reduce risk of infection and secure the supply chain.